Roche to present important new data reflecting broad cancer pipeline at ASCO
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
List view / Grid view
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
15 May 2013 | By Sanofi
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials...
Diabetes prevention has become a key focus area for the drug development market.
13 May 2013 | By DAIICHI SANKYO COMPANY, LIMITED
"Today’s announcement marks the resolution of this past issue..."
13 May 2013 | By Johnson & Johnson
The U.S. FDA has granted Priority Review to the NDA for simeprevir (TMC435)...
13 May 2013 | By Biogen Idec
The U.S. FDA has accepted BLA for the marketing approval of ELOCTATE™...
10 May 2013 | By GlaxoSmithKline
GlaxoSmithKline and Theravance announced that the US FDA has approved BREO™ ELLIPTA™...
10 May 2013 | By Novartis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab)...
9 May 2013 | By GlaxoSmithKline
Working together to accelerate the availability of two children’s medicines...
Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.
9 May 2013 | By Amgen
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
9 May 2013 | By GlaxoSmithKline
GSK's new commitment to the GAVI Alliance...
8 May 2013 | By TEVA
Teva and Alexza have entered into an exclusive U.S. license and supply agreement...
8 May 2013 | By Novartis
"Lucentis was designed to save sight..."
7 May 2013 | By B&W Tek
B&W Tek is pleased to announce the completion of its first series of educational videos...